An operational perturbation proteomics-based virtual cell model

Researchers developed ProteinTalks, a virtual cell model built from temporal protein-abundance measurements in systematically perturbed breast cancer cell lines, enabling computational prediction across diverse drug discovery tasks. The model leverages large-scale perturbation proteomics to capture dynamic cellular responses and translate them into an operational tool for identifying drug targets and mechanisms of action. Published in Nature, the work demonstrates the feasibility of data-driven virtual cell models as practical platforms for accelerating oncology drug development.